and :I:Department of Chemical Immunology, Weizmann Institute, Rehovot, Israel psoriatic lesions contain elevated levels of 1 ,2-diacylglycerol, the physiologic activator of protein kinase C (PKC), suggesting that PKC activation may be aberrant in psoriasis. We therefore have investigated the expression and properties of PKC isozymes in normal and psoriatic skin and in human skin cells. Chromatographic and immunoblot analyses revealed the presence of the calcium-dependent PKC isozymes PKC-cx and -fJ, but not -y, in normal human epidermis.
and yare calcium dependent, whereas PKC isozymes 6, E, (, 17, B, and A are calcium independent. Accumulating evidence indicates that certain PKC isozymes display distinct substrate specificities and requirements for activation, suggesting that they may possess functional specificity [10] [11] [12] [13] .
We have previously demonstrated that psoriatic lesions contain elevated phosphoinositide-specific phospholipase C activity and DAG content, compared to non-Iesional skin [14] . In addition, we have found that calcium-dependent PKC activity, determined by phosphorylation of histone ill lIilro,. is significantly reduced in psoriasis compared to normal skin [15] . Based on these observations, we have proposed that misregulation of the PKC signal transduction pathway may be an important participant in the pathophysiology of psoriasis [14, 15] . In this study , we extend our observations to demonstrate that reduced PKC activity in psoriatic lesions is largely due to reduced expression of PKC-j1II, which in normal skin is highly expressed in epidermal Langerhans cells, and to a lesser extent reduced PKC-a, which is expressed in all cel l types of the skin. In addition, we have characterized mRNA and protein expression of calcium-independent PKC isozymes 6, E, (, and 17 in normal and psoriatic skin.
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MATERIALS AND METHODS
Reagents Monoclonal antibodies to PKC-a and PKC-P (~hi c h detects both PKC-jJI and -jJII) were obtained from Selkagaku. Rabbit polyclonal antibodies to PKC-jJI , -jJII, -y, -0, -E, -(, and -II were prepared to synthetic peptides and characterized for specificity to each PKC isozyme expressed in the Bacu lovirus-insect cell expressIOn system [1 6]. Alkalllle phosphataseconjugated goat anti-rabbit IgG and alkaline phospharase-conjugated goat anti-mouse IgG were from Bio-Rad Laboratories. C hemiluminescent alkalinc phosphatase substrate (ECL} was from Amersham. M-MLV H-reverse transcriptase and rabbit globin mRNA were fro m Gibco BRL. TAQ DNA polymerase was obtained from Perkin Elmer Cetus. The ABC vectostall1 immunohistochemistry reage nt kit was from Vector LaboratOries. 3-Amino-9-cthyl carbazole was from Sigma C hemical Co mpany . Anti-CDb antibody was from Becton-Dickenson. Magnetic beads coated with goat anti-mouse IgG were obtained from Dyna!.
Tissue Procurement Keratome and punch biopsies from normal and psoriatic ep idermis were obtai ned as previous ly described [17] . Keratome bl ade depths were set at 0.2 mm and 0.4 mm for normal and psoriatic sk in , respectively, resulting in excision near the epidermal-dermal junction. Biopsies were composed of epidermis with some residual (approximately 5%) dermis, as judged by histologic exa mination. Biopsies were either used immediately or snap fro ze n in liquid nitroge n and stored at -70·C until used. All proced ures involvin g human subj ects were approved by the Universiry of Michigan Institutiona l Review Board.
Partial Purification and Assay of Soluble Calcium-Dependent PKC Previous studies demonstrated that 70 -80% of ca lcium-dependent PKC activity in human epidermis was in the so lubl e fraction [1 8] . Therefore the solubl e fraction of epidermal homogenates was utilized to characterize calc ium-depend ent PKC isozymes. Frozen keratome biopsies from normal and psoriatic skin were ground under liquid nitrogen with mortar and pestle and homogenized in a glass homogenizer in ice in 20 mM Tris-HCI (pH 7.5),5 mM ethyleneglyco l-bis(p-aminoethyl ether)-N ,N ,N',N'-tetraacetic acid (EGTA), 5 mM ethylenediami netctraacetic acid (EDTA) , 10 mM pmercaptoethanol, 0.1 % leupeptin. The homogenate was centrifu ged at 100,000 Xg for 1 h at 4·C, and the supernatant applied to a diethylaminoethyl-5 PW column (7 .5 X 0.75 cm), equ ilibrated with 20 mM Tris-HC l, (pH 7.5), 2 mM EGTA, 2 mM EDTA, 10 mM p-mercaptoethanol , 0.01 % leupeptin, connected to a Pharmacia fast protein liquid chromato graphy syste m. All chromatography was performed at 4·C in a co ld room. The colu mn was washed with 20 ml equilibration buffer and eluted with a linear grad ient of N aCl (0 -0.5 M) . Fractions (0. 5 ml) containin g PKC activity were pooled, diluted threefold with 5 mM KPO. (pH 7.5), 10% glycerol , 0.01 % leupeptin , and applied to a hi gh-performance hydroxylapitite colum n (10 X 0.78 cm) equilibrated with diluent. The column was eluted w ith a linear gradient of KPO. (5 -300 mM), and fractions (0.5 ml) were assayed for PKC activity.
Calci um-dependent PKC acti vity in column fractions was determined by measurement of PKC-c3talyzed incorpo ration of [32P]PO. into histo ne in th e presence of calcium, phospholipid, and TPA as previously described [1 8,19] .
Northern Blot Analysis Total RNA was isolated from keratome biopsies of norma l and pso riatic epidermis by ces ium chloride gradient centrifu ga tion as described [20] . Briefly, frozen keratome biopsies were ground under liquid nitroge n with mortar and pestle , and homogenized in a polytron homogenize r in guan idinium hyd rochloride lysis buffer (1 ml/ l00 mg wet weight). The resulting homogenate was ce ntrifu ged to remove insoluble debris and total RNA was obtained by cesium chloride gradient centrifugation. Po lyA+ RNA , obta ined by passage of total RNA over oligo-dT cellulose, was size fraction ated by electrophoresis on 1.2% formaldehyde agarose gels and transferred to nylon membrane. Membranes were probed with [32P]-labcled cDNA probes specific for PKC-cx, -{J, -0, -E, -(, and -~, generated by reverse transcriptase/polymerase chain reaction (see below) . cD NA probes were labeled by random priming. , Western Blot Analysis Soluble and particulate fractions from normal and psoriatic epidermis were prepared as described above, and equal amounts of protein (50 tJ.g) were resolved by sod ium dodecylsul fate-polyacry lamide gel electrophoresis (SDS-PAGE) (8% gels) [21) . Proteins were transferred to nitrocellulose membranes and blotted with specific antibodies to PKC-cx,-p (jJI and jJII) , -jJI , -jJII, -y, -0, -E, -(, and -~, usi ng standard procedures.
PKC/antibody compl exes were visualized by autoradio graphy usin g a chemiluminescent substrate. Recombinant PKC isozymes, obtai ned by expression in the Baculov irus-insect ce ll expression system, were used as standards .
Reverse Transcriptasc/Polymerase Chain Reaction Total RNA from keratome biopsies of normal and psoriatic epidermis and epidermal cel ls (keratinocytes, melanocytes, and Langcrhans cell s) was prepared as THE JOURNAL OF INVESTIGATIVE DERMATOLOGY described above. RNA (1 mg) was reverse transcribed, using random heximer primers (25 pmol) and 200 U M-MLV H-reverse transcriptase, at 37"C for 30 min in 50 mM Tris (pH 8. Polymerase chain reaction products were ana lyzed by agarose gel electro_ phoresis and visuali zed by ethidium bromide staining. The authenticity of each product was confirmed by size and digestion with two restriction enzy mes.
Reverse transcriptase/polymerase cha in reaction was also performed under conditions that allowed the relative levels of PKC isozyme transcripts in normal and psoriatic epidermis to be determined [22] . Rabbit globin mRNA (1.2 pg) and RNA from normal or pso riatic epide rmis (1 fig) were combined and reverse transcribed as described above. Following this, 3 fourfold di lutions of the reverse transcriptase reaction were made. T o each dilution, specific PKC isozy me and rabbit p-globin primers were added, and the target sequences for both co-a mplified as described above for 20 cycles. Polymerase chain reaction products were separated by agarose gel electro_ phoresis, transferred to nylon membrane, and simultaneously hybridized with [3 2 P]-labeled PKC isozyme and p-glob in probes (isolated polymerase chai n reaction products). Radioactivi ty in th e hybridized bands was quantifi ed using a PhosphorImager (Molecular Dynamics). Results are analyzed as the ratio of counts in the PKC isozy me band to counts in th e p-globin band. Over the concentration range of epidermal and rabbit glob in mRNA utili zed, the amount of poly merase chain reaction products formed after 20 cycles was linearl y proportional to the amou nt of RNA added.
Immunohistochemistry ofPKC-a and PKC-{J Punch biopsies for immunohistochemistry were oriented and embedded in gum tragacanth, snap frozen in isopent3ne chill ed in liquid nitrogen, and stored at -70 · C. Frozen cryostat sections (5 tl1n) of normal and psoriatic skin were stained with monoclonal antibod ies to PKC-cx and PKC-P, usin g an av id in-biotin peroxidase technique as described [17] . Peroxidase/a ntibody complexes were visualized with 3-amino-9-ethyl carbazole as substrate, and sections were co unterstained with 1 % hematoxylin. Normal mouse IgG was used as an isotype control and showed no specific staining.
Isolation of Langerhans Cells Keratome biopsies from normal epidermi s were trypsinized (0. 25%) to produce a cell suspension, wh ich was filtered through ny lon mesh to remove particulate debris. The cells were washed three times in calcium-, mag nesium-free phosphate buffered saline co ntaining 1 % fe tal bovine serum , and incubated on ice in RPM! 1640 co ntaining 10% fetal bovi ne serum , w ith mouse monoclonal antibody to CDla, for 30 min. Unbound anti-CD l a antibod y was removed by washing the cel ls three times as above, and the ce lls were incubated o n ice, with gentle agitation, with ma gnetic beads coated with goat anti-mouse IgG for 45 min [23] . Langerhans cells, rosetted with magnetic beads, were separated from non-C D la -bearing epidermal ce ll s by plac ing the epidermal cel l suspension next to a fix ed magnet for 5 min. T he Langerh alls cells-depleted epidermal cel ls were removed by pipette fro m the magne t-bound Langerhans cells. Lange rhans cells were se parated from the epidermal cell suspension twice more with addition al beads, as above, and the rosected Langerhans cel ls poo led. This procedure resulted in an epiderma l ce ll suspension that was depleted of Langerhans cel ls by greater than 98%, and a preparation of Langerhans ce ll s that was 90% pure, as assessed by CO l a staining.
Culture of Human Keratinocytes and Melanocytes Adult human keratinocytcs and mclanocytes were cultured from keratome biopsies of VOL. 101, NO.4 OCTOBER 1993
A B Figure 1 . Immunoblot analysis ofPKC-a and PKC-P in normal and psori c atic human epidermis following chromatographic separation. A) PKC activities in the so lubl e fraction from normal human epidermis (10 mg) were partially purified by c~1I'0m a to gra phy on a DEAE-5PW co lumn. Fr~ctions containing PKC activity were pooled and applied to a hydroxylapatite column to separate calcium-depend ent PKC isoe nzymcs. This yielded two peaks of PKC activity, which were separately pooled, and analyzed by immunoblot with monoclonal antibodies to PKC-a (Ieji) and PKC-P (right).
RB, p artially purified PKC from rat brain used as a positive control; normal skin as previously described [24, 25) . Briefly, keratome biopsies were crypsi nized (0.25%) to produce an epidermal cell suspension a~1 d primary cu ltures containing mostly keratll1ocytes, but II1cludll1g 1-10 Vo melanocytes, were grown in co mplete MCDB 153 [24) . After approximately 1 week cultures were briefly treated with trypsin (0.025%) to preferentially remo~e mel anocytes, and the melanocytes were seeded in fresh dishes in complete MCDB 153 containin g 10 11M TPA .. TPA stll11ul ated melanocyte o liferation, wlllle causll1g any reSIdual keratmocytes to term1l1ally dlfferpr
. " e l f entiate and detach from the dish. Keratmocytes remallllng arter rcmova 0 melanocytes were further trypsinized and expandcd by passage 111 complete MCDB 153.
RESULTS
Measurement of Calcium-Dependent PRC Isozymes in Normal and Psoriatic Epidermis We have previously reported that norma l human epidermis expresses PKC activity that is calcIUm dependent and phosphorylates histone ill lIitro [18] , suggest1l1g that human skin expresses one or more of the ca l~1Um-depend~nt PKC isozymes a, /1, and )'. To further examine tillS, PKC ~CtiVlty from normal human epidermis was partially purified by lugh-performance DEAE chromatography (this yielded a single peak of calcmmdependent PKC activity, data not shown), and the calciumdependent PKC isozymes resolved b~ chromatog raphy on hydroxylapatite. Two dlstll1Ct peaks of calcIum-dependent PK<? aCtiVIty, which eluted at 100 mM and 170 mM KP0 4 , were obtall1ed from hydroxylapatite chromatogr.aphy (data not shown~. The first peak conta ined approximately twIce as much PKC actIvIty as the seco nd peak. Based on the known elution positions of PKC-a, -/1, and -y [26, 27] ' peaks one and two would be expected to contain PKC-/1 and -a, respectively. No peak of ac tivity corresponding to the expected elution position of PKC-)' (40 mM KP0 4 ) w as observed. The absence of a PKC-y peak w as not due to faIlure to resolve PKC-y from PKC-/1, because we were able to resolve PKC-y and PKC-/1 in rat brain under similar conditions (data not shown).
To confirm the presence ofPKC-a and PKC-/1 in human epidermis, immunoblot analysis of the two peaks ofPKC activity resolved by hydroxylapatite chromatography was pe~formed, using. specific monoclo nal antibodies. The first peak of actIvIty reacted wIth antIbody to PKC-/1, but not antibody to PKC-a, and the second peak reacted with PKC-a antibody, but not PKC-/1 antibody (Fi g lA).
N either peak ofPKC activity reacted with antibody to PKC-y (data PKC ISOENZYMES IN HUMAN SKIN 555 not shown). These data demonstrate that norma l human epidermis expresses PKC-a and PKC-/1 in an approximate ratio of 1 : 2. We previously reported that psoriatic skin lesions contain significa ntl y less calcium-dependent PKC activity than normal epidermis [53] . We th erefore next determined the levels ofPKC-a, -/1, and -y in psoriati c les ions by resolution on h ydroxylapa tite chromatography and immunoblot, as described above. Similar to normal epidermis, two peaks ofPKC activity were obtained from psoriatic epid ermis, with elution positions corresponding to PKC-/1 and PKC-a (data not shown). The identity of these two peaks o f PKC activity as PKC-a and PKC-/1 was confirmed by immunoblot (data not shown) . C hromatography of equal amo unts of protein from normal and psoriatic epidermis on hydroxylapa tite revealed that the levels of both PKC-a and -/1 were reduced in psori atic epidermis, compared to normal epidermis. PKC-a was reduced 20 ± 5% (n = 6), whereas PKC-/1 activity was preferentially decreased 80 ± 9% (n = 6), such that the ratio of PKC-a to PKC-/1 was reversed fro m that seen in normal epidermis to 2: 1. The preferential loss ofPKC-/1 activity in pso riatic epidermis was observed in six of six psoriatic individuals. T ake n together, the reduction in ac tivity ofPKC-a and -/1 resulted in a 60% reduction in total calcium-dependent PKC activity. This value is similar to o ur previously reported value for reduction in PKC activity in psorias is [15] .
Fractions from h ydroxylapatite chrom atograph y of normal and psoriatic epidermis containing PKC activity were pooled, concentrated, and an alyzed by immunoblot to determine the protein levels of PKC-a and PKC -/1. The relative levels of PKC-a and -/1 immunoreactive proteins in normal and psoriatic epidermis were found to be proportional to the relative levels ofPKC-a and -/1 activi ties (Fig  lB) . In psori atic epidermis, both immunoreactive PKC-a and -/1 were reduced, compared to no rma l epidermis, with preferential loss of PKC-/1 (the lane containing PKC-/1 from psoriatic epidermis contained four times more protein th an the corresponding lane from normal epidermis) . The above data demonstrate that the previously observed decrease in calcium-dependent PKC activi ty in psoriatic epidermis is due to decreases in both PKC-a and -/1 activity and protein expression, w ith preferential loss of PKC-/1.
Properties of Epidermal PRe-a and -/l We next examined the enzymatic properties of PKC-a and -/1 fro m normal and psoriatic epidermis with respect to activa tion by calcium , TPA, and fatty acids. Both PKC-a and -/1 from norm al and psoriatic epidermis required phosphatidylserine and calcium for activ ity, with maximal activation, in the prese nce of 100 J.lM phosphatidylserine, observed at 100 J.lM calcium (data not shown) . PKC-a and PKC-/1 from normal and psoriatic epidermis were also similarly stimulated by TPA. In the prese nce of phosphatidylserine (100 J.lM) and calcium (1 J.lM) maximal activation (tenfold) was observed at 10 nM TPA (data not shown). Interestin gly, both PKC-a and PKC-/1 from normal and psoriatic epidermis were significantly stimulated by unsaturated fa tty acids, in the abse nce of phosphatidylserine. Stimulation increased with increasi ng chai n len gth and degree of unsaturation, with arachidonic acid being the most potent of the fatty acids tested. Arachidonic acid stimulated PKC-a to nearly 100% of the maximal value obtained in the presence of phosph atidylserine, calcium , and TPA (Fig 2A) , whereas PKC-/1 was stimulated to nearly 60 % of maximal ( Fig 2B) . The addition of calcium had a negli gible effect on activation of PKC-a or PKC-/1 by aTachidonic acid (data not shown).
Immunohistochemical Localization ofPRC-a and -/lin Normal and Psoriatic Human Epidermis We next examined by immunohistochemistry the cellular locali zation ofPKC-a and -/1 in normal and psoriatic skin. PKC-a inuTIul10reactivity in norm al skin was observed througho ut all the layers of living cells of the epidermis, with the highest intensity in the lower layers of keratinocytes (Fig 3A) . A similar stainin g pattern, although of decreased intensity, was observed within the epidermis of psoriatic skin, and, in add ition, PKC-a staining was observed in inflammatory cells within the dermis (Fig 3B) . In contrast to PKC-a, PKC-/1 immunoreactivity was observed primaril y in the upper two thirds of no rmal epidermis, with intense staining within a small number of scattered cells (Fig 3C). In psoriatic skin, PKC-/3 stal11l11g was greatly diminished within the epidermis. Intense focal staining of cells observed in normal epidermis was essen tiall y absent (Fig 3D) . Prominent staining of inflammatory cells within the dermis and epidermis, which was absent in normal skin, was observed in psoriatic sk in. T he location and appearance of the intensely PKC-/3 staining cells observed in normal epidermis identifies them as Langerhans cell s. To determine whether loss of Langerhans cell PKC-/3 immunoreactivity in psoriasis was due to reduced nUlnbers of Langerhans cells, or to reduced Langerhans cell PKC-/3 expression, tissue sections of normal and psoriatic skin were stained with antibodies to COla, a specific marker for epidermal Langerhans cells. The morphology and location within the epidermis of COla-positive Langerhans cell s were similar in normal epidermis and psoriatic lesions (data not shown). There was no difference in the number of CDlapositive Langerhans cell s in tissue sections from normal epidermis (14.9 ± O.5/HPF, n = 7) and psoriatic lesions (-15.7 ± 1, n = 7).
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Taken together, the above data demonstrate that although CDlapositive Langerhans cells are present in normal numbers in psoriatic skin, they express little, if any, immunoreactive PKC-/3.
The intensity of Langerhans cell PKC-/3 staining suggests that Langerhans cells, which comprise only 1 -2% of the total cells in human epidermis, may contain a disproportionately large amo unt of PKC activity. To determine the contribution of Langerhans cell PKC-/3 to the total calcium-dependent PKC activity in normal epidermis, epidermal cell suspensions were depleted of Langerhans cells by immunoabsorption onto magnetic beads. In three experiments, Langerhans cells depletion resulted in 12 -25% decreases in the total calcium-dependent PKC activity (Table I) . mRNA Levels of Calcium-Dependent and -Independent PKC Isozymes in Normal and Psoriatic Epidermis The above data indicate that human epidermis expresses PKC-a and -/3, but not PKC-y, and that PKC-/3 is preferentially decreased in psoriatic epidermis. We next examined expression of the calcium-independent PKC isozymes in normal and psoriatic epidermis. PKC mRNA expression was determined by reverse transcription/polym_ erase chain reaction, using primers specific for eight human PKC isozymes. Polymerase chain reaction products of the correct sizes were obtained for PKC-a, as expected, and for PKC-fJi, PKC-fJiI, PKC-o, PKC-E, PKC-C, and PKC-1l (Fig 4) . Consistent with biochemical studies, no mRNA for PKC-y was detected (data nor shown) . PKC-fJII mRNA was detected in all samples examined, whereas that ofPKC-/31 was detectable in approximately one-half of the sa mpl es. The frequency of occurrence of PKC-/3l mRNA w as similar in normal and psoriatic epidermis (data not shown) . The authenticity of each polymerase chain reaction product was confirmed by digestion with two restriction enzymes (data not shown). Northern analysis of polyA+ RNA from pooled samples of normal and psoriatic epiderm is (pooling of biopsies from three to four individuals was necessary to obtain sufficient quantities of total RNA to prepare polyA+ RNA) revealed transcripts for each of the PKC isozymes identified by polymerase chain reaction (Fig 5) . The sizes of the transcripts were similar to those reported for PKC isozymes from humans and rodents [28] [29] [30] [31] [32] [33] [34] . Transcripts from PKC-o, -C, and -1'/ were detectable on Northern blots of total RNA from normal and psoriatic epidermis, whereas those for PKC-a:, -/3, and -E were .. Epidermal cel l suspensions were prepared from keratome biopsies of no rlllal human skin by trypsinization. Cells (8 - 10 7 ) were incubated with magnetic beads coated with anti-CD 1 a antibody or isotype IgG (control) to adsorb COl a+ r..,ngerhans cells. Beads were removed w ith a mag net. and control and Langer"ans cell -depleted cell suspensions were homogenized and assayed for protein kinase C activity as described in Materials "lid Meth ods.
THE JOURNAL OF INVESTI GATIVE DERMATOLOGY
not (data not shown), suggesting that these latter mRNAs were less abundant. In th e pooled sa mples shown, no apparent differences in relati ve band intensities between normal and psoriatic epidermis were observed for any of the PKC isozymes.
Because it is difficult to prepare sufficient amounts of polyA+ RN A, needed for Northern analysis, from a single individual's skin biopsy, PKC isozy me mRNA levels in norma l and psoriatic individuals w ere determined by reverse transc riptasejpol ymerase chain reaction, under quantitative conditions. This method utilizes total
RNA and is at least 1,000 times more sensitive than Northern analysis. mRNA levels for each of the six PKC isozyme genes expressed in human skin were determined in biopsies from six normal and six psoriatic subjects. This analys is revea led no significant differences between normal and psoriatic epidermis, for any of the PKC isozy m es (data not shown) . These data indi.cate that the observed decrease in PKC-a and -fJ activity and protellllll psonasls (Fig 1) IS not associated with a corresponding decrease in their mRNA levels.
Protein Levels of Calcium-Independent PKC Isozymes in NorDlal and Psoriatic Epidermis W e next determined the relative protein levels of the calcium-independent PKC isozymes in biopsies from normal and psoriatic epidermis. Biopsies were separated into soluble and particular fractions and PKC isozymes measured by immunob lot. PKC-o was equally distributed between the soluble and membrane fractions, PKC-E was predominantly found in th e particu late fraction, w hereas PKC-( and -17 were mostly in the soluble fraction (Fi g 6). The levels of PKC-o, PKC-E, and PKC-17
we re similar in normal and psoriatic epidermis. In contrast, soluble PKC-( was elevated twofold in pso riatic , co mpared to normal, epidermis (Fi g 6). Figure 5 . Northern blot ana lys is of PKC isozymes in normal and psoriatic epid ermis. PolyA+ RNA (10 Ilg/ Iane) was prepared from three pooled b,ops,es fro m normal (N) and psoriatic (P) skin , and hybridized with cDNA probes for PKC-a, fl, J, E, 1/, and t;,. ge nerated by polymerase chain reaction (see Fig 6) . The size of the major transc ripts for cac h PKC isozyme is show n on the leJi.
PKC Isozyme Expression in Individual Cell Types in Human
Skin The above data demonstrate that normal and psoriatic human epidermis express PKC isozymes a, {JI, {JII , 0, E, (, and '7. As epidermis is composed primarily of three different cell types, keratinocy tes, melanocytes, and Langerhans cel ls, we determined the PKC isozyme composition in eac h cel l type. For this purpose primary cultures of keratinocytes an d melanocytes were propagated from bIOpSies of no rmal human epidermis. Because it is not possible to culture pure Langerhans cells, th ese cells were isolated from fres h epidermal cell suspensions by il11l11unoabso rption on m ag netic beads. The presence of transcripts for eac h of eight PKC isozymes in these three cell types was determined by reverse transcriptasejpolymerase chain reaction. Keratinocytes were found to express transcripts for each of the six PKC isozymes present in human epidermis, PKC-a, -fJ, -0, -E, -(, and -II (Fig 7 A) . Melanocytes and Langerhans cells, however, expressed distinct subsets of these enzy mes. Melanocy tes contained transcrip ts for PKC-a, PKC-fJ, PKC-o,and PKC-( (Fig 7B) , whereas Langerhans cells expressed predomlllantly PKC-{JII, . Th ese data indicate th at within human epidermis PKC-E and PKC-Il are expressed exclusivel y by keratinocytes, whereas the remaining four PKC isozy mes are expressed in two or mo re cell types. -.
-- Figure 6 . Immunoblot analys is of calcium-independent PKC isozymcs in normal and psoriatic epidermis. Normal and psoriatic epidermis were separated into solubl e (SUPE) and particulate (PELLET) frac tions and analyzed for PKC-J, E, r., and 'I, usin g specific polyclollal antibodies. Each lane con- 
DISCUSSION
Skin is well known to be a sensitive target for the actions of tumorpromoting phorbol esters such as TPA. The biologic effects of these agents are primarily mediated by PKe. Topical treatment of human or rO'dent skin with TPA results in a robust response characterized by keratinocyte ac tivation (i.e., both growth and terminal differentiation are accelerated) and inflamma tion [35, 37] . Our demonstration that six of the genes that encode members of the PKC family are expressed within human epidermis provides insight into the molecular basis for the actions of TPA in skin, and provides ev idence for the potential complexity of PKC-mediated signaling pathways in this tissue.
The enzymatic properties of human skin PKC-a and -P were similar to those reported for these PKC isozymes in a variety of other tissues [38, 39] . The observed activation of PKC-a and -P by unsaturated fatty acids, particularly arac hidonic acid, is of interest because arachidonic acid levels are highly elevated in psoriatic skin [40] . The levels of arac hidonic acid in psoriatic epidermis are approximately 50 11M, which in vitro was sufficient to activate epidermal PKC-a and -P to 100% and 60% of maximal, respectively.
Recent evidence indicates that arachidonic acid preferentially activates soluble, rather than membrane-associated, PKC [41] . In psoriatic epidermis, therefore, soluble PKC-a and -P may be activated by elevated arachidonic acid, whereas membrane-associated PKC-a and -P may be activated by elevated DAG. We have previously reported that DAG levels are increased threefold in psoriatic skin [14] . In addition, recent evidence indicates that arac hidonic acid and DAG can synergisticall y activate protein kinase C-P, -E, and -y [42] .
Because many of the biochemical and histologic features of the skin disease psoriasis resemble those ofTPA-treated skin, we compared the expression of PKC isozymes in normal epidermis to that of psoriatic epiderm is. We observed that the major difference was decreased PKC-P in psoriatic lesions. This is consistent with our previous finding of decreased calci um-dependent PKC activity in psoriatic epidermis [15] . Unexpectedly, in view of their relatively sma ll nl)mber, Langerhans cells were found to be a significant source ofPKC-P in normal epidermis. These cells, which represent 1 -2% of the total epidermal cells, contained approximately 20% of the total calcium-dependent PKC activity (i.e., PKC-a + PKC-fl).
Given that PKC-a and PKC-P are present in a ratio of approximately 1 : 2 in normal epidermis, and that Langerhans cells do not express PKC-a, Langerhans cells account for approximately 30% of the total PKC-P in normal human epidermis. This indicates that on a per-cell basis Langerhans cells contain 10-20 times more PKC-P THE JOURNAL OF INVESTIGATIVE DERMATOLOGY than keratinocytes. This conclusion is consistent with data demonstrating high levels of PKC-P expression in Langerhans cells in mouse skin [73] .
In psoriatic skin, Langerhans cells PKC-pwas virtually absent, as determined by immunohistochemistry. Although this may have been due to altered epitope availability rather than decreased PKC-P protein, additional biochemical and immunologic data demonstrated that this was not the case. Chromatographic resolution of calcium-dependent PKC isozymes revea led preferential loss of PKC-P activity in psoriatic epidermis, and this finding was consistent with reduced PKC-P as determined by immunoblot analysis. The physiologic significance of the preferential loss ofPKC-P from Langerhans cells in psoriasis remains to be determined. It is especially intriguing, however, in view of accumulating evidence identifying the importance of the immune system in the pathophysiology of psoriasis. Findings from clinical and laboratory studies suggest that abnormal T-cell activation serves as a key mechanism in this disease [44, 45] . Because Langerhans cells function, similar to macrophages, to process and present antigens to T cells, they are intimately involved in the regulation ofT-cell activatio n. Evidence suggests that PKC is involved in macrophage activation (46) (47) (48) and may therefore function similarly in Langerhans cells.
Reduced PKC-P in Langerhans cells in psoriatic epidermis may I reflect PKC activation, with subsequent downregulation. Activation of PKC increases its susceptibility to proteolytic degradation, resulting in reduced PKC levels in a process termed "dowruegula_ tion." We [48] have previously demonstrated that calcium-dependent PKC activity is downregulated in mouse and human skin following topical treatment with TPA. Alternatively, reduced PKC-P in Langerhans cells in psoriatic epidermis may reflect reduced synthesis, although the finding that PKC-P mRNA levels were not reduced suggests that this is less likely. It is also possible that the reduction of PKC-P in Langerhans cel ls, rather than in addition to its activation, may have important consequences for Langerhans cell function in psoriasis. Elucidation of this issue must await further studies.
Within keratinocytes, PKC-a was expressed predominantly in the lower epidermal laye rs, whereas PKC-P was present in the more mature cells in the upper epidermal layers. This suggests that the expression of these two calcium-dependent PKC isozymes may be regulated as a function of keratinocyte maturation, and may therefore act to transduce signals in a differentiation-specific manner. Similarly, the calcium-independent PKC isozymes may also be ex-I pressed at different stages of keratinocyte maturation. Our attempts to localize the calcium-independent PKC isozymes within the epidermis by immunohistochemistry using the polyclonal antibodies used for immunoblot were unsuccessful due to high background. This is a common problem encountered when staining skin sections with rabbit antibodies, due to cross reactivity to skin keratins.
In normal and psoriatic skin, PKC-Il was predominantly found in the soluble fraction. This is in contrast to a recent report demonstrating nuclear localization of PKC-I] in A-431 cells [49] . This difference may be due to differential localization of PKC-I] in normal keratinocytes versus transformed epidermoid cells, or to differences in preparation of subcellular frac tions between this and the previous study . Our method of homogenization involves the grinding of frozen tissue followed by thawing. In separate studies, we have observed that this procedure results in the disruption of nuclei. It is possible, therefore, that during homogenization PKC-I] m ay have been released from nuclei into the soluble fraction.
Each of the three major cell types in human epidermis expressed at least one calcium-dependent and one calcium-independent PKC isozyme. Consistent with our results obtained by polymerase chain reaction, Gherzi et al [50] recently reported expression of PKC-a:, -0, and -I] mRNA in cultured human keratinocytes using Northern analysis . These investigators failed, however, to detect mRNA for PKC-P, -E, and -C. This may have been due to lower sensitivity, as oligonucleotide probes based on mouse PKC isozyme cDNA sequences were utilized. Co-expression of calcium-dependent and independent PKC isozymes occurs in many cell tyyes, and suggests that PKC isozymes possess functional specificity [1, 8, 9] . Increased
